Telomere dynamics in pluripotent stem cells derived from patients with telomere diseases (2011)
- Authors:
- Winkler, Thomas - National Institutes of Health (NIH)
- Decker, Jake E.
- Hong, So Gun - National Institutes of Health (NIH)
- Wu, Chuanfeng - National Institutes of Health (NIH)
- Morgan, Mary J. - National Institutes of Health (NIH)
- Dunbar, Cynthia E. - National Institutes of Health (NIH)
- Young, Neal S. - National Institutes of Health (NIH)
- Calado, Rodrigo Tocantins
- Autor USP: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
- Unidade: FMRP
- Subjects: ENZIMAS; CROMOSSOMOS; GENÉTICA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2011
- Source:
- Conference titles: Annual Meeting and Exposition of the American Society of Hematology (ASH)
-
ABNT
WINKLER, Thomas et al. Telomere dynamics in pluripotent stem cells derived from patients with telomere diseases. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 20 jan. 2026. , 2011 -
APA
Winkler, T., Decker, J. E., Hong, S. G., Wu, C., Morgan, M. J., Dunbar, C. E., et al. (2011). Telomere dynamics in pluripotent stem cells derived from patients with telomere diseases. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Winkler T, Decker JE, Hong SG, Wu C, Morgan MJ, Dunbar CE, Young NS, Calado RT. Telomere dynamics in pluripotent stem cells derived from patients with telomere diseases. Blood. 2011 ; 118( 21):[citado 2026 jan. 20 ] -
Vancouver
Winkler T, Decker JE, Hong SG, Wu C, Morgan MJ, Dunbar CE, Young NS, Calado RT. Telomere dynamics in pluripotent stem cells derived from patients with telomere diseases. Blood. 2011 ; 118( 21):[citado 2026 jan. 20 ] - Immunologic aspects of hypoplastic myelodysplastic syndrome
- Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH)
- Androgen treatment mitigates hematopoietic cell telomere attrition in vivo
- Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation
- Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT
- Treatment of inherited bone marrow failure syndromes beyond transplantation
- Etiopatogênese da anemia aplástica adquirida: fatores genéticos e mecanismos de resistência a drogas
- Telomere dynamics in mice and humans
- Variações da qPCR e seus usos
- Células reprogramadas. [Depoimento a Hérika Dias e Luis Ribeiro]
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
